Take this CSID Doctor Discussion Guide and 4-Day Trial Rx
form to your next appointment.
Any one or combination of these
symptoms could indicate CSID.
Congenital Sucrase-Isomaltase Deficiency (CSID) is a rare, inherited digestive disorder where the small intestine produces little or no sucrase-isomaltase enzyme—the enzyme needed to properly break down sucrose (table sugar). This condition affects the body’s ability to break down sugar (sucrose) and starch, leading to digestive symptoms, especially after meals.
If you have been diagnosed with CSID,
ask your GI doctor if Sucraid® is right for you.
Download the CSID
Doctor Discussion Guide and 4-Day Trial Rx form.
"*" indicates required fields
Sucraid® is an enzyme replacement therapy and the only
FDA-approved medication indicated for the treatment of CSID.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
Sucraid® (sacrosidase) Oral Solution is an enzyme replacement therapy for the treatment of genetically determined sucrase deficiency, which is part of
Congenital Sucrase-Isomaltase Deficiency (CSID).